New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation

Detalhes bibliográficos
Principais autores:	Coates, L, Murphy, R, Helliwell, P
Formato:	Journal article
Idioma:	English
Publicado em:	Wiley 2016

Registros relacionados

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis
por: Coates, L, et al.
Publicado em: (2017)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
por: Soriano, ER, et al.
Publicado em: (2023)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
por: Coates, LC, et al.
Publicado em: (2022)

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences
por: Coates, L, et al.
Publicado em: (2022)

Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations
por: Palominos, PE, et al.
Publicado em: (2022)

Screening/referral strategies for the early recognition of psoriatic arthritis (PsA) among patients with psoriasis: results of a GRAPPA survey
por: Song, K, et al.
Publicado em: (2023)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
por: Tillett, W, et al.
Publicado em: (2020)

A presença da reumatologia brasileira no GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) The presence of the Brazilian rheumatology in the GRAPPA
por: Cláudia Goldenstein-Schainberg, et al.
Publicado em: (2011-10-01)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
por: Poddubnyy, D, et al.
Publicado em: (2021)

Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
por: Coates, L, et al.
Publicado em: (2016)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
por: Denis Poddubnyy, et al.
Publicado em: (2021-12-01)

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
por: Tillett, W, et al.
Publicado em: (2017)

GRAPPA 2016 Project Report
por: Helliwell, P, et al.
Publicado em: (2017)

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group
por: Leung, Y-Y, et al.
Publicado em: (2023)

GRAPPA treatment recommendations: updates and methods
por: Kavanaugh, A, et al.
Publicado em: (2020)

Methotrexate in psoriasis and psoriatic arthritis
por: Coates, L, et al.
Publicado em: (2020)

Identification of psoriatic arthritis in patients with psoriasis
por: Coates, LC, et al.
Publicado em: (2023)

Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
por: Orbai, A-M, et al.
Publicado em: (2019)

Psoriasis and Psoriatic Arthritis in ChildhoodPsoriasis and Psoriatic Arthritis in Childhood
por: Nikolay N. Murashkin, et al.
Publicado em: (2020-12-01)

GRAPPA 2018 project report
por: Goel, N, et al.
Publicado em: (2019)

Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative
por: Antony, A, et al.
Publicado em: (2021)

Assessment of two screening tools to identify psoriatic arthritis in patients with psoriasis
por: Coates, L, et al.
Publicado em: (2018)

Current concepts and unmet needs in psoriatic arthritis
por: Mahmood, F, et al.
Publicado em: (2017)

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set
por: Leung, Y, et al.
Publicado em: (2019)

GRAPPA 2019 project report
por: Goel, N, et al.
Publicado em: (2020)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
por: P.S. Helliwell
Publicado em: (2011-09-01)

The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates
por: Leung, YY, et al.
Publicado em: (2020)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology consensus‐based recommendations and research agenda for use of composite measures and treatment targets in psoriatic arthritis
por: Coates, L, et al.
Publicado em: (2017)

Itolizumab – A New Biologic for Management of Psoriasis and Psoriatic Arthritis
por: Ganesh Pai, et al.
Publicado em: (2017-08-01)

New opportunities in the treatment of psoriasis and psoriatic arthritis
por: A. A. Kubanov, et al.
Publicado em: (2019-01-01)

Small Molecules in the Management of Psoriasis and Psoriatic Arthritis
por: Venkata Chalam Konakanchi, et al.
Publicado em: (2024-06-01)

Is axial psoriatic arthritis the same as ankylosing spondylitis with psoriasis: a debate
por: Coates, LC, et al.
Publicado em: (2023)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: V. Ibba, et al.
Publicado em: (2011-09-01)

EPIDEMIOLOGY OF PSORIASIS AND PSORIATIC ARTHRITIS
por: M.A. Cimmino
Publicado em: (2011-09-01)

Assessing disease activity in psoriatic arthritis: a literature review
por: Tucker, L, et al.
Publicado em: (2018)

Hot topice debate: preventing psoriatic arthritis in patients with psoriasis
por: Vivekanantham, A, et al.
Publicado em: (2024)

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative
por: De Marco, G, et al.
Publicado em: (2020)

New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?
por: Matteo Megna, et al.
Publicado em: (2021-10-01)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast.
por: Palfreeman, A, et al.
Publicado em: (2013)

IMMUNE PATHOGENESIS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: S. V. Smirnova, et al.
Publicado em: (2014-08-01)